thiophenes has been researched along with Age-Related Osteoporosis in 191 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.52) | 18.7374 |
| 1990's | 2 (1.05) | 18.2507 |
| 2000's | 82 (42.93) | 29.6817 |
| 2010's | 100 (52.36) | 24.3611 |
| 2020's | 6 (3.14) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsen, B; Arden, N; Calderon-Larranaga, S; Cooper, C; Hawley, S; Javaid, MK; Judge, A; Khalid, S; Prieto-Alhambra, D; Sami, A; Van Staa, TP | 1 |
| Elgebaly, Z; Elliott, J; Naik-Panvelkar, P; Norman, S; Pollack, A; Seibel, MJ; Thistlethwaite, J; Weston, C | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Haraguchi, R; Imai, Y; Kitazawa, R; Kitazawa, S; Kohara, Y | 1 |
| Guo, HF; Jin, J; Li, ZR; Liu, ZY; Xie, ZS; Xue, ST; Yi, H; Zhang, L | 1 |
| Dereka, X; Donos, N; Mardas, N; Patel, M; Stavropoulos, A | 1 |
| Kosiorowska, J; Szymańska-Chabowska, A; Tański, W | 1 |
| Huerta-Álvarez, C; Martín-Merino, E; Montero-Corominas, D; Prieto-Alhambra, D | 1 |
| Dong, Q; Li, JY; Li, MH; Liao, NN; Wang, Y | 1 |
| Dempster, DW; Moreira, CA | 1 |
| Berzina-Cimdina, L; Loca, D; Locs, J; Pilmane, M; Salma-Ancane, K | 1 |
| Cook, AE; Diepenhorst, N; Langmead, CJ; Pastoureau, P; Rueda, P; Sabatini, M | 1 |
| Ahrabi, A; Böker, KO; Harlas, B; Hoffmann, DB; Komrakova, M; Kosinsky, RL; Saul, D; Sehmisch, S; Wassmann, M; Wigger, R | 1 |
| Ding, GZ; Tao, ZS; Wang, L; Wu, XJ; Xie, JB; Xu, ZJ; Yang, M; Zhang, X; Zhou, WS | 1 |
| Chen, X; Geng, T; Guo, H; Jin, Q; Sun, S; Yu, H; Zhang, S; Zheng, M | 1 |
| Das, N; Gupta, T; Imran, S | 1 |
| Bei, MJ; Cao, GL; Geng, LD; Liu, GY; Song, HP; Tian, FM; Yuan, LL; Zhang, L; Zheng, ZY | 1 |
| Cao, X; Cao, Y; Chai, Y; Chen, H; Deng, R; Dong, X; Gao, B; Guan, Y; Hu, B; Jain, A; Liu, S; Lv, X; Ni, S; Wan, M; Wang, L; Wang, X; Yang, H; Yang, M; Yuan, W; Zhen, G; Zhu, S | 1 |
| He, F; Lin, Z; Lu, T; Shi, H; Wu, T; Yang, S; Ye, J; Zhang, J | 1 |
| Adeeb, SM; Doschak, MR; Duke, MJ; Munoz-Paniagua, D; Wu, Y | 1 |
| Duque, G | 1 |
| Feola, M; Liuni, FM; Pistillo, P; Saturnino, L; Scialdoni, A; Tarantino, U; Tempesta, V | 1 |
| Chapurlat, R; Chavassieux, P; Meunier, PJ; Pierre, M; Portero-Muzy, N; Roux, JP | 1 |
| Capaldo, A; Di Somma, C; Gimigliano, F; Iolascon, G; Menditto, E; Orlando, V | 1 |
| Bertoldo, F; Di Monaco, M; Giusti, A; Martini, G; Rossini, M; Varenna, M | 1 |
| Hamilton, JL; Ross, RD; Sumner, DR; Virdi, AS; Wilson, BM | 1 |
| Brandi, ML; Collette, J; Dawson-Hughes, B; Fardellone, P; Kaufman, JM; Reginster, JY; Rizzoli, R; Vellas, B | 1 |
| Abrahamsen, B; Grove, EL; Vestergaard, P | 1 |
| Donneau, AF; Reginster, JY | 1 |
| Geusens, P; Lems, WF | 1 |
| Beaudart, Ch; Bruyere, O; Buckinx, F; Disteche, S; Neuprez, A; Reginster, JY; Slomian, J | 1 |
| Kurth, A | 1 |
| Compston, J | 1 |
| Gosch, M; Kammerlander, C; Nicholas, JA | 1 |
| Gambacciani, M; Levancini, M | 1 |
| Carotti, A; Cozzoli, L; Gargano, EM; Hanke, N; Hartmann, RW; Marchais-Oberwinkler, S; Perspicace, E | 1 |
| Reginster, JY | 2 |
| Brown, SL; Cassim, B; Davey, MR; de Lange, W; de Villiers, TJ; Ellis, GC; Hough, FS; Lipschitz, S; Lukhele, M; Pettifor, JM | 1 |
| Bouvet, A; Caruba, T; Pouchot, J; Sabatier, B; Savoldelli, V | 1 |
| Bolland, MJ; Grey, A | 1 |
| Beaudart, C; Bruyere, O; Dardenne, N; Emonts, P; Neuprez, A; Reginster, JY | 1 |
| Biczók, Z; Bor, A; Doró, P; Gyimesi, N; Matuz, M; Soós, G | 1 |
| Reid, IR | 1 |
| Conti, V; Corbi, G; D'Argenio, V; Ferrara, N; Filippelli, A; Filippelli, W; Grimaldi, M; Maffulli, N; Russomanno, G; Simeon, V; Toro, G | 1 |
| Brandi, ML; Cannata-Andía, J; Cooper, C; Cortet, B; Feron, JM; Genant, H; Palacios, S; Reginster, JY; Ringe, JD; Rizzoli, R | 1 |
| Guo, HF; Jin, J; Ju, DH; Li, ZR; Liu, MJ; Liu, ZY; Xue, ST | 1 |
| Chen, LX; Feng, SQ; Li, YL; Ning, GZ; Zhang, D; Zhang, TS; Zhou, ZR | 1 |
| Anselme, K; Farina, M; Querido, W | 1 |
| Agostino, RM; Basile, G; Bellone, F; Bruno, LM; Catalano, A; Gaudio, A; La Rosa, MA; Lasco, A; Morabito, N; Morini, E; Piraino, B; Salpietro, C; Tsiantouli, E | 1 |
| Andreopoulou, P; Hegde, V; Jo, JE; Lane, JM | 1 |
| Eimer, C; Hoffmann, DB; Hofmann, AM; Komrakova, M; Saul, D; Sehmisch, S; Stürmer, KM; Tezval, M; Wassmann, M | 1 |
| Ang, SB; Chan, MM; Lee, HY; Lim, YL; Pang, SM; Ren, EC; Shen, MX; Tay, YK; Xiao, ZW | 1 |
| Almeida, MM; Joly, JC; Martinez, EF; Nani, EP; Napimoga, MH; Peruzzo, DC; Teixeira, LN | 1 |
| Kim, YT; Oda, H; Sugiyama, T | 1 |
| Hoffmann, DB; Komrakova, M; Nuehnen, V; Sehmisch, S; Stueber, H; Stuermer, KM; Tezval, M; Wassmann, M; Wicke, M | 1 |
| Matikainen, N | 1 |
| Amling, M; Busse, B; Grynpas, M; Niecke, M; Riedel, C; Zimmermann, EA; Zustin, J | 1 |
| Chen, LH; Chen, WJ; Fu, TS; Ho, NY; Lai, PL; Niu, CC; Tai, CL; Tsai, TT | 1 |
| Abrahamsen, B; Eiken, PA | 1 |
| de Villiers, TJ | 1 |
| Fonseca, JE | 1 |
| Pongchaiyakul, C; Songpattanasilp, T; Taechakraichana, N | 1 |
| Dydykina, IS; Tsurko, VV | 1 |
| Laroche, M | 1 |
| Guven, GS; Kilicarslan, A; Oz, SG; Sozen, T; Tanriover, MD | 1 |
| Fukawa, T; Kamiya, S; Wada, S | 1 |
| Kaliterna, DM | 1 |
| Neuprez, A; Reginster, JY | 2 |
| Ammann, P; Bain, SD; Dupin-Roger, I; Jerome, C; Shen, V | 1 |
| Foo, AC; Glendenning, P; Inderjeeth, CA; Lai, MM | 1 |
| Anastasilakis, AD; Avramidis, A; Papatheodorou, A; Polyzos, SA; Terpos, E | 1 |
| Aaron, L; Autret-Leca, E; Crickx, B; Hartingh, I; Jonville-Béra, AP | 1 |
| Adachi, JD; Josse, RG; Kendler, DL; Slosman, DO | 1 |
| de la Peña, MP; Farrerons, J; Hawkins, F; Ish-Shalom, S; Kapetanos, G; Kekow, J; Marin, F; Möricke, R; Oertel, H; Recker, RR; Sanz, B; Stepan, J | 1 |
| Cortet, B | 2 |
| Bergamini, P; Franceschetti, T; Lambertini, E; Marchesi, E; Pagnoni, A; Penolazzi, L; Piva, R | 1 |
| Masuda, H; Tanaka, S | 1 |
| Guo, HF; He, XB; Li, X; Li, ZR; Liu, ZY; Shao, HY; Si, SY; Yang, ZY; Zhang, YQ | 1 |
| Blake, GM; Compston, JE; Fogelman, I | 1 |
| Belissa-Chatelain, P; Cournarie, F; Dupin-Roger, I; Tsouderos, Y | 1 |
| Bruyere, O; Deroisy, R; Hiligsmann, M; Neuprez, A; Reginster, JY; Zegels, B | 1 |
| Hamdy, NA | 1 |
| Boivin, G; Marie, PJ; Meunier, PJ | 1 |
| Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P | 2 |
| Feng, G; Gao, Y; Hu, J; Li, Y; Liu, X; Luo, E | 1 |
| Bolland, MJ; Gamble, GD; Grey, AB; Reid, IR | 1 |
| Guo, HF; He, XB; Jiang, JD; Li, X; Li, ZR; Liu, ZY; Shao, HY; Si, SY; Xue, ST; Yang, ZY; Zhang, YQ | 1 |
| Chappard, D; de Vernejoul, MC; Geoffroy, V; Lalande, A; Libouban, H; Marty, C; Ostertag, A | 1 |
| Cai, DH; Chen, H; Huang, Z; Lai, AN; Sun, P; Yang, R; Zhang, H; Zhang, Z | 1 |
| Ringe, JD | 1 |
| Ferrari, S | 1 |
| Bandeira, F; Coutinho, Mde A; Diniz, ET; Griz, L; Marques, TF; Sousa, IO | 1 |
| Barbagallo, M; Dominguez, LJ; Scalisi, R | 1 |
| Dorst, A; Farahmand, P; Ringe, JD | 1 |
| Silverman, SL | 1 |
| Bruyère, O; Hiligsmann, M; Neuprez, A; Reginster, JY; Vanoverberghe, M | 1 |
| Berthelot, JM; Glémarec, J; Guillot, P; Le Goff, B; Maugars, Y | 1 |
| Alexandersen, P; Byrjalsen, I; Christiansen, C; Karsdal, MA | 1 |
| Guo, WJ; Lei, W; Qi, W; Wang, PJ; Yan, YB; Zhang, Y | 1 |
| Abellan Van Kan, G; Boonen, S; Gillette-Guyonnet, S; Rolland, Y; Roux, C; Vellas, B | 1 |
| Marie, PJ | 4 |
| Bachmeyer, C; Gauthier, M | 1 |
| Einhorn, TA; Morgan, EF; Sibai, T | 1 |
| Mosekilde, L; Rejnmark, L; Schwartz, F; Vestergaard, P | 1 |
| Goëb, V; Trouvin, AP | 1 |
| Davis, M; Fisher, A; Martin, J; Srikusalanukul, W | 1 |
| Landfeldt, E; Lang, A; Robbins, S; Ström, O | 1 |
| Jørgensen, NR; Schwarz, P | 1 |
| Almeida, MO; Bandeira, F; Carvalho, NN; Salgado, CL; Voss, LA | 1 |
| Brazier, M; Fardellone, P; Kamel, S; Mentaverri, R | 1 |
| Lam, RW; Li, Z; Lu, WW; Pan, H; Peng, S; Tang, B | 1 |
| Lakatos, P | 1 |
| Giusti, A; Pedrazzoni, M; Pioli, G | 1 |
| Chen, K; Hu, J; Li, X; Li, Y; Song, G; Yin, G | 1 |
| Fang, DY; Liang, QC; Liao, EY; Liu, LH; Ma, YL; Sheng, ZF; Tong, D; Zhang, J | 1 |
| Bergmann, P; Body, JJ; Boonen, S; Devogelaer, JP; Gielen, E; Goemaere, S; Kaufman, JM; Reginster, JY; Rozenberg, S | 1 |
| Boeckhoff, J; Hadji, P; Kostev, K; Kyvernitakis, I; Ziller, V | 1 |
| Davey, DA | 1 |
| Boivin, G; Doublier, A; Farlay, D | 1 |
| Berköz, M; Comelekoglu, U; Eroglu, P; Sagír, O; Yalin, S | 1 |
| Adamski, J; Hartmann, RW; Marchais-Oberwinkler, S; Meyer, A; Möller, G; Negri, M; Odermatt, A; Perspicace, E; Wetzel, M; Xu, K | 1 |
| Audran, M; Bianchi, G; Boonen, S; Braga, V; Diaz-Curiel, M; Felsenberg, D; Francis, RM; Goemaere, S; Josse, R; Kaufman, JM; Palacios, S; Ringe, JD | 1 |
| Ben Sedrine, W; Bruyère, O; Hiligsmann, M; Reginster, JY | 1 |
| Briongos, L; Dueñas-Laita, A; García-Alonso, M; Pérez-Castrillón, JL; Ruiz-Mambrilla, M; Sañudo, S | 1 |
| Biskobing, DM; Downs, R; Novy, AM | 1 |
| Boivin, G; Meunier, PJ | 1 |
| Sasaki, T; Suda, T; Takahashi, N; Tsouderos, Y | 1 |
| Hough, S | 1 |
| Deroisy, R; Lecart, MP; Lousberg, C; Reginster, JY | 1 |
| Adami, S; Gatti, D; Viapiana, O | 1 |
| Ammann, P; Bonjour, JP; Mauras, Y; Rizzoli, R; Robin, B; Shen, V | 1 |
| Ammann, P | 2 |
| Parfitt, AM; Riggs, BL | 1 |
| Chapurlat, R; Delmas, PD | 1 |
| Tsakok, AD | 1 |
| Simon, LS | 2 |
| Fogelman, I | 1 |
| Blake, GM; Fogelman, I | 3 |
| Barton, IP; Boonen, S; Laan, RF; Watts, NB | 1 |
| Boivin, G; Farlay, D; Lalande, A; Meunier, PJ; Panczer, G | 1 |
| Geusens, P; Reid, D | 1 |
| Dimai, HP | 1 |
| Burckhardt, P | 1 |
| Attia, M; Claude, JR; Dargent, F; de Jouffrey, S; Dupin-Roger, I; Fisch, C | 1 |
| Hauser, T; Mazurov, A; Miller, CH | 1 |
| Collette, J; Manette, C; Reginster, JY; Sarlet, N; Tancredi, A; Zegels, B | 1 |
| Kleerekoper, M | 1 |
| Fassbender, WJ; Stumpf, UC | 1 |
| Kaji, H; Sugimoto, T | 1 |
| Roux, C | 1 |
| Duque, G; Retornaz, F | 1 |
| Cremers, S; Garnero, P | 1 |
| Bilezikian, JP; Girotra, M; Rubin, MR | 1 |
| Ariogul, S; Cankurtaran, M; Gedik, A; Halil, M; Haznedaroglu, IC; Kirazli, S; Piskinpasa, S; Ulger, Z; Yavuz, BB | 1 |
| Nakamura, T | 2 |
| Cherkas, LF; Richards, JB; Spector, TD | 1 |
| Keen, R | 1 |
| Denhardt, DT; Ezura, Y; Kato, N; Kitahara, K; Kurosawa, H; Nakashima, K; Noda, M; Rittling, SR | 1 |
| Bors, K | 1 |
| Albanese, C; Brixen, K; Bruyere, O; Detilleux, J; Devogelaer, JP; Diaz-Curiel, M; Fardellone, P; Kaufman, JM; Pors-Nielsen, S; Reginster, JY; Roux, C; Slosman, DO; Spector, TD | 1 |
| Krieg, MA; Lamy, O | 1 |
| Robb-Nicholson, C | 1 |
| Inoue, D | 1 |
| Delmas, PD; Vignot, E | 1 |
| Díez Pérez, A | 1 |
| Shiraki, M | 1 |
| Blahos, J | 1 |
| Novak, S | 1 |
| Ambrus, JL; Francis, K; Moore, R; Robin, JC; Rosenstein, M; Sharma, SD; Thomas, CC; Vida, JA | 1 |
| De Pollak, C; Deloffre, P; Guillemain, J; Hott, M; Marie, PJ; Modrowski, D; Tsouderos, Y | 1 |
| Bhargava, A; Bombara, M; Caringal, Y; Dally, R; Dumas, J; Gunn, D; Housley, TJ; Johnson, JS; Kingery-Wood, J; Lee, W; Osterhout, M; Paulsen, H; Ranges, GE; Redman, AM; Renick, J; Scott, WJ; Shrikhande, A; Smith, RA; Swartz, S; Wild, H; Wilhelm, SM; Young, D | 1 |
| Auberval, M; Baron, R; Bodary, S; Breipohl, G; Carniato, D; Doucet, B; Gadek, TR; Gaillard, M; Gourvest, J; Knolle, J; Peyman, A; Ruxer, J; Scheunemann, K; Stilz, HU; Wehner, V; Will, DW | 1 |
| Anderson, PW; Barrett-Connor, E; Cox, DA; Harper, K; Mosca, L; O'Gorman, J; Sarkar, S | 1 |
79 review(s) available for thiophenes and Age-Related Osteoporosis
| Article | Year |
|---|---|
Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
Topics: Alendronate; Bone Density Conservation Agents; Cohort Studies; Databases, Factual; Diabetes Mellitus; Diphosphonates; Humans; Myocardial Infarction; Osteoporosis; Primary Health Care; Renal Insufficiency, Chronic; Risk Assessment; Selective Estrogen Receptor Modulators; Thiophenes; United Kingdom | 2022 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Osteoporosis - risk factors, pharmaceutical and non-pharmaceutical treatment.
Topics: Cholecalciferol; Denosumab; Dietary Supplements; Diphosphonates; Exercise; Humans; Kinesiology, Applied; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Teriparatide; Thiophenes | 2021 |
Strontium and strontium ranelate: Historical review of some of their functions.
Topics: Animals; Humans; Organometallic Compounds; Osteoporosis; Strontium; Thiophenes | 2017 |
G protein-coupled receptors as anabolic drug targets in osteoporosis.
Topics: Humans; Models, Biological; Molecular Targeted Therapy; Osteoporosis; Receptors, G-Protein-Coupled; Teriparatide; Thiophenes | 2018 |
The Prevention and Therapy of Osteoporosis: A Review on Emerging Trends from Hormonal Therapy to Synthetic Drugs to Plant-Based Bioactives.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Male; Middle Aged; Osteoporosis; Phytochemicals; Phytotherapy; Plants, Medicinal; Selective Estrogen Receptor Modulators; Synthetic Drugs; Thiophenes | 2019 |
Osteoporosis in older persons: current pharmacotherapy and future directions.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Humans; Osteoporosis; Thiophenes | 2013 |
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Humans; Osteoporosis; Thiophenes; Vitamin D | 2013 |
Pharmacologic augmentation of implant fixation in osteopenic bone.
Topics: Animals; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Combined Modality Therapy; Diphosphonates; Fracture Fixation; Fractures, Bone; Humans; Orthopedic Fixation Devices; Osseointegration; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Prostheses and Implants; Thiophenes | 2014 |
Established and forthcoming drugs for the treatment of osteoporosis.
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Cathepsin K; Denosumab; Diphosphonates; Humans; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Thiophenes; Vitamin D | 2014 |
Treatment of osteoporosis in older adults.
Topics: Aged; Aging; Antibodies, Monoclonal, Humanized; Bone Density; Denosumab; Diphosphonates; Female; Frail Elderly; Hormone Replacement Therapy; Humans; Kidney Diseases; Male; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Teriparatide; Thiophenes | 2014 |
Cardiac concerns associated with strontium ranelate.
Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Contraindications; Fractures, Bone; Humans; Osteoporosis; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes | 2014 |
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record.
Topics: Bone Density Conservation Agents; Drug and Narcotic Control; Humans; Myocardial Infarction; Osteoporosis; Osteoporotic Fractures; Periodicals as Topic; Pulmonary Embolism; Research Report; Risk Assessment; Thiophenes; Venous Thromboembolism | 2014 |
Efficacy and safety of currently marketed anti-osteoporosis medications.
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Humans; Indoles; Osteoporosis; Parathyroid Hormone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes | 2014 |
The position of strontium ranelate in today's management of osteoporosis.
Topics: Bone Density Conservation Agents; Drug Approval; Drug Prescriptions; Humans; Osteoporosis; Risk Assessment; Thiophenes; Treatment Outcome | 2015 |
Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Humans; Hydroxycholecalciferols; Ibandronic Acid; Imidazoles; Lumbar Vertebrae; Osteoporosis; Parathyroid Hormone; Risedronic Acid; Teriparatide; Thiophenes; Zoledronic Acid | 2015 |
Effect of osteoporosis medications on fracture healing.
Topics: Anabolic Agents; Animals; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fracture Healing; Humans; Osteoporosis; Osteoporotic Fractures; Thiophenes | 2016 |
[Osteoporosis: a clinical perspective].
Topics: Absorptiometry, Photon; Accidental Falls; Alcohol Drinking; Algorithms; Bone Density Conservation Agents; Calcium, Dietary; Diphosphonates; Exercise; Gonadal Steroid Hormones; Humans; Osteoporosis; Osteoporotic Fractures; Risk Assessment; Risk Factors; Smoking Cessation; Thiophenes; Vitamin D | 2016 |
[Osteoporosis treatment can be discontinued based on an individual assessment].
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Diphosphonates; Humans; Middle Aged; Osteoporosis; Precision Medicine; Teriparatide; Thiophenes; Withholding Treatment | 2017 |
The quest for new drugs to prevent osteoporosis-related fractures.
Topics: Benzoates; Biphenyl Compounds; Bone Density Conservation Agents; Drug Discovery; Humans; Osteoporosis; Osteoporotic Fractures; Piperidines; Propanolamines; Pyrrolidines; Tetrahydronaphthalenes; Thiophenes | 2017 |
Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength.
Topics: Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Resorption; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis; Thiophenes; Uncoupling Agents | 2008 |
Osteoporosis: overview in disease, epidemiology, treatment and health economy.
Topics: Calcium; Diphosphonates; Fractures, Bone; Humans; Incidence; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators; Thailand; Thiophenes; Vitamin D | 2008 |
[Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivalos)].
Topics: Bone Density Conservation Agents; Cost of Illness; Cost-Benefit Analysis; Humans; Organometallic Compounds; Osteoporosis; Prognosis; Thiophenes | 2008 |
Treatment of osteoporosis: all the questions we still cannot answer.
Topics: Age Factors; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Fractures, Bone; Hormone Replacement Therapy; Humans; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Teriparatide; Thiophenes; Time Factors | 2008 |
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Drug Design; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Indoles; Organometallic Compounds; Osteoporosis; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Zoledronic Acid | 2008 |
[Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2008 |
Bone-forming agents in the management of osteoporosis.
Topics: Aged; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis; Teriparatide; Thiophenes | 2008 |
Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
Topics: Alendronate; Bone Density Conservation Agents; Etidronic Acid; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Risedronic Acid; Teriparatide; Thiophenes | 2009 |
Monitoring strontium ranelate therapy in patients with osteoporosis.
Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Clinical Trials as Topic; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Thiophenes; Treatment Outcome | 2009 |
[Drugs under development for osteoporosis ].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cathepsin K; Cathepsins; Denosumab; Diphosphonates; Drug Design; Humans; Ibandronic Acid; Imidazoles; Organometallic Compounds; Osteoporosis; Osteoprotegerin; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes | 2009 |
Strontium ranelate: new data on fracture prevention and mechanisms of action.
Topics: Bone Density Conservation Agents; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Thiophenes; Treatment Outcome | 2009 |
Strontium ranelate improves bone microarchitecture in osteoporosis.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Disease Models, Animal; Humans; Organometallic Compounds; Osteoporosis; Rats; Thiophenes | 2009 |
Effect of osteoporosis treatment on mortality: a meta-analysis.
Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Organometallic Compounds; Osteoporosis; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Thiophenes; Treatment Outcome; Zoledronic Acid | 2010 |
Strontium ranelate: an effective solution for diverse fracture risks.
Topics: Body Mass Index; Bone Density Conservation Agents; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Risk Factors; Smoking; Thiophenes | 2010 |
Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture.
Topics: Aged; Biopsy; Bone and Bones; Bone Density Conservation Agents; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis; Thiophenes | 2010 |
Therapeutic options in osteoporosis.
Topics: Accidental Falls; Alcoholism; Bone Density Conservation Agents; Calcium, Dietary; Diet; Diphosphonates; Estrogens; Exercise; Fractures, Bone; Hip Injuries; Humans; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Patient Compliance; Protective Devices; Selective Estrogen Receptor Modulators; Smoking; Teriparatide; Thiophenes; Vitamin D | 2010 |
New selective estrogen receptor modulators (SERMs) in development.
Topics: Bone Density Conservation Agents; Breast Neoplasms; Female; Humans; Indoles; Osteoporosis; Piperidines; Pyrrolidines; Risk Factors; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes | 2010 |
Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
Topics: Age Factors; Aged; Aged, 80 and over; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Costs; Evidence-Based Medicine; Female; Fractures, Bone; Humans; Male; Models, Economic; Organometallic Compounds; Osteoporosis; Patient Selection; Risk Assessment; Sex Factors; Thiophenes; Treatment Outcome | 2010 |
A comparison between bisphosphonates and other treatments for osteoporosis.
Topics: Bone Density Conservation Agents; Diphosphonates; Drug Costs; Drug Monitoring; Female; France; Humans; Male; Medication Adherence; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes | 2010 |
Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Humans; Models, Biological; Organometallic Compounds; Osteocytes; Osteoporosis; Thiophenes | 2010 |
Strontium ranelate: a look back at its use for osteoporosis.
Topics: Animals; Bone Density Conservation Agents; Cost-Benefit Analysis; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2010 |
Anabolic agents and bone quality.
Topics: Adaptor Proteins, Signal Transducing; Anabolic Agents; Animals; Bone and Bones; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Remodeling; Focal Adhesion Kinase 2; Fracture Healing; Genetic Markers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin-Like Growth Factor I; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Peptide Fragments; Prostaglandins; Teriparatide; Thiophenes | 2011 |
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss.
Topics: Aging; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Female; Humans; Male; Mice; NF-kappa B; Organometallic Compounds; Osteoblasts; Osteoclasts; Osteoporosis; Osteoprotegerin; RANK Ligand; Rats; Thiophenes | 2010 |
Effects of anti-osteoporosis medications on fracture healing.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Fracture Healing; Fractures, Bone; Humans; Models, Animal; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Thiophenes | 2011 |
Potential anti-catabolic and anabolic properties of strontium ranelate.
Topics: Bone Density; Bone Density Conservation Agents; Bone Remodeling; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis; RANK Ligand; Thiophenes | 2012 |
[Pharmacologic treatment of osteoporosis--2011].
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Denosumab; Diphosphonates; Drug Costs; Drug Therapy, Combination; Estrogen Replacement Therapy; Humans; Hungary; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; RANK Ligand; Teriparatide; Thiophenes; Vitamin D | 2011 |
Novel therapeutic options for osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid | 2002 |
Strontium ranelate in osteoporosis.
Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Calcium; Cell Differentiation; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Models, Animal; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes; Tissue Distribution | 2002 |
The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Topics: Animals; Bone Density; Bone Remodeling; Bone Resorption; Calcium; Female; Haplorhini; Humans; Male; Minerals; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome | 2003 |
Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate.
Topics: Animals; Bone Density; Bone Development; Bone Resorption; Haplorhini; Humans; Mice; Models, Animal; Organometallic Compounds; Osteoporosis; Rats; Thiophenes | 2003 |
New anabolic agents in the treatment of osteoporosis.
Topics: Anabolic Agents; Bone Density; Bone Remodeling; Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin-Like Growth Factor I; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Sodium Fluoride; Thiophenes | 2003 |
Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Topics: Animals; Humans; Molecular Structure; Organometallic Compounds; Osteoporosis; Thiophenes | 2004 |
Strontium ranelate: a novel mode of action leading to renewed bone quality.
Topics: Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Stimulation, Chemical; Thiophenes; Uncoupling Agents | 2005 |
Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone Development; Bone Resorption; Clinical Trials, Phase III as Topic; Collagen; Collagen Type I; Female; Haplorhini; Humans; Mice; Models, Animal; Organ Culture Techniques; Organometallic Compounds; Osteoporosis; Ovariectomy; Peptides; Rats; Thiophenes; Uncoupling Agents | 2005 |
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
Topics: Adult; Age Factors; Aged; Aging; Anabolic Agents; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Bone Resorption; Female; Humans; Middle Aged; Models, Biological; Norpregnenes; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Terminology as Topic; Testosterone; Thiophenes; Time Factors | 2005 |
[New treatments in osteoporosis].
Topics: Aged; Bone Remodeling; Diphosphonates; Female; Fractures, Bone; Humans; Injections, Subcutaneous; Middle Aged; Organometallic Compounds; Osteoporosis; Postmenopause; Risk Factors; Teriparatide; Thiophenes | 2004 |
Osteoporosis.
Topics: Alkaline Phosphatase; Androgens; Bone Remodeling; Calcitonin; Calcium; Diagnosis, Differential; Diphosphonates; Estrogens; Fractures, Bone; Glucocorticoids; Humans; Organometallic Compounds; Osteoclasts; Osteoporosis; Parathyroid Hormone; Sodium Fluoride; Thiophenes | 2005 |
Where now for the management of osteoporosis?
Topics: Calcium; Diphosphonates; Humans; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Practice Guidelines as Topic; Receptors, Estrogen; Thiophenes; Vitamin D | 2005 |
Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Etidronic Acid; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis; Randomized Controlled Trials as Topic; Risedronic Acid; Thiophenes | 2005 |
Strontium as therapy for osteoporosis.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Humans; Organometallic Compounds; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes | 2005 |
Newer drug treatments: their effects on fracture prevention.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Fractures, Bone; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Imidazoles; Organometallic Compounds; Osteoporosis; Osteoprotegerin; Parathyroid Hormone; RANK Ligand; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Thiophenes; Zoledronic Acid | 2005 |
[Strontium ranelate: a novel concept for the treatment of osteoporosis].
Topics: Animals; Bone Density; Bone Development; Bone Resorption; Clinical Trials as Topic; Fractures, Spontaneous; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2005 |
Strontium ranelate: a physiological approach for an improved bone quality.
Topics: Animals; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis; Ovariectomy; Postmenopause; Rats; Stress, Mechanical; Thiophenes | 2006 |
Selective alpha7 nicotinic acetylcholine receptor ligands.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bone and Bones; Disease Models, Animal; Female; Humans; Ligands; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Receptors, Nicotinic; Thiophenes | 2006 |
Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
Topics: Animals; Bone and Bones; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes | 2006 |
Osteoporosis prevention and therapy: preserving and building strength through bone quality.
Topics: Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes | 2006 |
[Anabolic treatment for osteoporosis: PTH treatment].
Topics: Anabolic Agents; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Thiophenes | 2006 |
[Osteoporosis in the elderly].
Topics: Accidental Falls; Adult; Age Factors; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Diagnosis, Differential; Diphosphonates; Exercise; Female; Femoral Fractures; Fractures, Bone; Frail Elderly; Humans; Incidence; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Quality of Life; Risk Factors; Sex Factors; Spinal Fractures; Teriparatide; Thiophenes; Vitamin D; Vitamin D Deficiency | 2006 |
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Neoplasms; Bone Remodeling; Bone Resorption; Calcitonin; Cathepsin K; Cathepsins; Collagen Type I; Denosumab; Diphosphonates; Drug Administration Schedule; Drug Design; Female; Humans; Organometallic Compounds; Osteitis Deformans; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; RANK Ligand; Thiophenes | 2006 |
Anabolic skeletal therapy for osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Female; Fractures, Bone; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Risk Factors; Teriparatide; Thiophenes | 2006 |
[Therapeutic agents for disorders of bone and calcium metabolism. Osteoporotic fracture prevention by strontium ranelate].
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Bone Density; Bone Resorption; Clinical Trials as Topic; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis; Spinal Fractures; Thiophenes | 2007 |
Osteoporosis: strategies for prevention and management.
Topics: Calcitonin; Diphosphonates; Disease Management; Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Life Style; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Risk Factors; Selective Estrogen Receptor Modulators; Thiophenes | 2007 |
Osteoporosis.
Topics: Bone Density; Bone Remodeling; Bone Resorption; Calcitonin; Estrogen Replacement Therapy; Fractures, Bone; Humans; Organometallic Compounds; Osteoclasts; Osteoporosis; Thiophenes | 2007 |
[Up-to-date treatments for osteoporosis].
Topics: Bone Density; Bone Density Conservation Agents; Bone Regeneration; Calcitonin; Calcium Compounds; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Fluorides; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Testosterone; Thiophenes; Vitamin D | 2006 |
[Current and future prospects for anti-osteoporotic drugs].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cholecalciferol; Clinical Trials as Topic; Denosumab; Diphosphonates; Drug Administration Schedule; Drug Design; Humans; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Patient Compliance; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Thiophenes | 2007 |
[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Clinical Trials as Topic; Drug Design; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Receptors, Calcium-Sensing; Thiophenes | 2007 |
Treatment and prevention of osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium, Dietary; Combined Modality Therapy; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Exercise; Humans; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D | 2007 |
[Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis].
Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Resorption; Cathepsin K; Cathepsins; Drug Design; Genetic Markers; Humans; Organometallic Compounds; Osteoblasts; Osteoporosis; Parathyroid Glands; RANK Ligand; Teriparatide; Thiophenes | 2008 |
[Strontium ranelate (Osseor)--unique double mechanism--physiologic bone treatment as live tissue].
Topics: Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes | 2007 |
13 trial(s) available for thiophenes and Age-Related Osteoporosis
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.
Topics: Administration, Oral; Alendronate; Biopsy; Bone and Bones; Female; Humans; Middle Aged; Osteoporosis; Thiophenes | 2014 |
Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients.
Topics: Aged; Cholecalciferol; Female; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Strontium; Thiophenes; Vitamin D; Vitamin D Deficiency | 2014 |
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.
Topics: Adaptor Proteins, Signal Transducing; Adult; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Remodeling; Female; Genetic Markers; Humans; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Osteoporosis; Thiophenes | 2016 |
Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Female; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis; Prospective Studies; Teriparatide; Thiophenes | 2009 |
Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
Topics: Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis; Postmenopause; Teriparatide; Thiophenes | 2009 |
Efficacy of strontium ranelate on bone mineral density in men with osteoporosis.
Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Body Height; Bone Density; Bone Density Conservation Agents; Endpoint Determination; Fractures, Bone; Hip; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Prospective Studies; Spine; Thiophenes | 2010 |
Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis.
Topics: Aged; Biomarkers; Bone Density Conservation Agents; Collagen Type I; Creatinine; Female; Humans; Organometallic Compounds; Osteoarthritis; Osteoporosis; Peptides; Postmenopause; Thiophenes | 2011 |
Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Female; Humans; Male; Organometallic Compounds; Osteoporosis; Spinal Fractures; Thiophenes | 2011 |
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Humans; Male; Organometallic Compounds; Osteoporosis; Thiophenes; Treatment Outcome | 2013 |
Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Topics: Animals; Humans; Molecular Structure; Organometallic Compounds; Osteoporosis; Thiophenes | 2004 |
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
Topics: Aged; Bone Density; Calcium; Double-Blind Method; Female; Femur; Femur Neck; Follow-Up Studies; Fractures, Bone; Humans; Logistic Models; Middle Aged; Organometallic Compounds; Osteoporosis; Risk Reduction Behavior; Spinal Fractures; Spine; Thiophenes; Treatment Outcome; Vitamin D | 2007 |
Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.
Topics: Adult; Aged; Aged, 80 and over; Causality; Female; Humans; Hypertriglyceridemia; Middle Aged; Osteoporosis; Pancreatitis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Triglycerides | 2001 |
101 other study(ies) available for thiophenes and Age-Related Osteoporosis
| Article | Year |
|---|---|
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
Topics: Aged; Aged, 80 and over; Attitude of Health Personnel; Australia; Bone Density Conservation Agents; Denosumab; Deprescriptions; Diphosphonates; Drug Substitution; Female; General Practice; General Practitioners; Humans; Longitudinal Studies; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; Thiophenes | 2020 |
Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of
Topics: Aging; Animals; Cell Survival; Cells, Cultured; Gene Expression Regulation, Developmental; Hedgehog Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoclasts; Osteogenesis; Osteoporosis; Pyridines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Signal Transduction; Smoothened Receptor; Thiophenes; Up-Regulation; Veratrum Alkaloids; X-Ray Microtomography; Zinc Finger Protein GLI1; Zinc Finger Protein Gli2 | 2020 |
Substituted benzothiophene and benzofuran derivatives as a novel class of bone morphogenetic Protein-2 upregulators: Synthesis, anti-osteoporosis efficacies in ovariectomized rats and a zebrafish model, and ADME properties.
Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Caco-2 Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Molecular Structure; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes; Zebrafish | 2020 |
The role of strontium ranelate and guided bone regeneration in osteoporotic and healthy conditions.
Topics: Animals; Bone Regeneration; Cattle; Female; Humans; Osteoporosis; Rats; Rats, Wistar; Thiophenes | 2021 |
Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Cohort Studies; Denosumab; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Primary Health Care; Risk Factors; Spain; Teriparatide; Thiophenes; Withholding Treatment | 2017 |
[Changes of TGF-β1 expression during orthodontic tooth movement in rats with osteoporosis].
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Humans; Male; Molar; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Periodontium; Rats; Rats, Sprague-Dawley; Thiophenes; Tooth Movement Techniques; Transforming Growth Factor beta1 | 2017 |
Histomorphometric changes following treatment for osteoporosis.
Topics: Anabolic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Clinical Trials as Topic; Humans; Osteoporosis; Teriparatide; Thiophenes; Treatment Outcome; Zoledronic Acid | 2017 |
Effect of Strontium Ranelate on the Muscle and Vertebrae of Ovariectomized Rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Lumbar Vertebrae; Muscle, Skeletal; Osteoporosis; Ovariectomy; Rats, Sprague-Dawley; Thiophenes | 2018 |
Prevention of ovariectomy-induced osteoporosis in rats : Comparative study of zoledronic acid, parathyroid hormone (1-34) and strontium ranelate.
Topics: Animals; Bone Density Conservation Agents; Female; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Thiophenes; X-Ray Microtomography; Zoledronic Acid | 2019 |
Effects of strontium ranelate on wear particle‑induced aseptic loosening in female ovariectomized mice.
Topics: Aged; Alendronate; Animals; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Female; Humans; Mice; Osteocalcin; Osteoclasts; Osteogenesis; Osteolysis; Osteoporosis; Osteoprotegerin; Prosthesis Failure; Thiophenes | 2018 |
Strontium Ranelate Combined with Insulin Is as Beneficial as Insulin Alone in Treatment of Fracture Healing in Ovariectomized Diabetic Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Fracture Healing; Fractures, Bone; Humans; Insulin; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Thiophenes | 2018 |
Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Bone and Bones; Bone Density; Bone Regeneration; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Feedback, Physiological; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoblasts; Osteoporosis; Propranolol; Pyridines; Receptors, Prostaglandin E, EP4 Subtype; Sensory Receptor Cells; Thiophenes | 2019 |
Strontium ranelate simultaneously improves the radiopacity and osteogenesis of calcium phosphate cement.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Marrow Cells; Calcium Phosphates; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Compressive Strength; Culture Media; Gene Expression Profiling; Ions; Materials Testing; Mesenchymal Stem Cells; Mice; Minimally Invasive Surgical Procedures; Osteoclasts; Osteogenesis; Osteoporosis; Rheology; Stress, Mechanical; Thiophenes | 2019 |
Compositional and material properties of rat bone after bisphosphonate and/or Strontium ranelate drug treatment.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Calcium; Diphosphonates; Female; Hardness Tests; Osteoporosis; Ovariectomy; Phosphorus; Rats; Rats, Sprague-Dawley; Strontium; Thiophenes; X-Ray Microtomography | 2013 |
Strontium ranelate for osteoporosis in men. More dangerous than beneficial.
Topics: Aged; Bone Density Conservation Agents; Humans; Male; Organometallic Compounds; Osteoporosis; Thiophenes | 2013 |
Fracture healing in elderly patients: new challenges for antiosteoporotic drugs.
Topics: Aged; Bone and Bones; Bone Density Conservation Agents; Female; Fracture Fixation, Internal; Fracture Healing; Frail Elderly; Humans; Humeral Fractures; Osteoporosis; Osteoporotic Fractures; Radiography; Thiophenes | 2013 |
Osteoporosis drugs in real-world clinical practice: an analysis of persistence.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Drug Substitution; Etidronic Acid; Female; Humans; Ibandronic Acid; Male; Middle Aged; Osteoporosis; Retrospective Studies; Risedronic Acid; Thiophenes | 2013 |
Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Cardiovascular Diseases; Cause of Death; Databases, Factual; Denmark; Drug Utilization; Female; Humans; Male; Middle Aged; Osteoporosis; Registries; Risk Factors; Thiophenes; Treatment Outcome | 2014 |
Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice.
Topics: Bone Density Conservation Agents; Cardiovascular Diseases; European Union; Humans; Osteoporosis; Pharmacovigilance; Thiophenes | 2014 |
Bone forming agents for the management of osteoporosis.
Topics: Adaptor Proteins, Signal Transducing; Aged; Animals; Antibodies, Monoclonal; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Resorption; Europe; Female; Genetic Markers; Humans; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Teriparatide; Thiophenes | 2014 |
[Strontium ranelate for osteoporosis treatment].
Topics: Bone Density; Bone Density Conservation Agents; Humans; Male; Organometallic Compounds; Osteoporosis; Thiophenes | 2014 |
Strontium ranelate lives to fight another day.
Topics: Bone Density Conservation Agents; Drug Approval; Humans; Organometallic Compounds; Osteoporosis; Strontium; Thiophenes | 2014 |
Management of postmenopausal osteoporosis and the prevention of fractures.
Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Hormone Replacement Therapy; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Phytoestrogens; Radiography; Risk Factors; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Treatment Outcome | 2014 |
Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; Drug Design; Enzyme Inhibitors; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Inhibitory Concentration 50; Ketones; Mice; Models, Molecular; Molecular Conformation; Osteoporosis; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Thioamides; Thiophenes | 2014 |
The safety of osteoporosis medication.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Calcitonin; Calcium; Cardiovascular Diseases; Constipation; Diarrhea; Diphosphonates; Esophagitis; Estrogen Replacement Therapy; Fractures, Bone; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes; Vitamin D | 2014 |
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; France; Hip Fractures; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Prescriptions; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D; Wrist Injuries; Zoledronic Acid | 2014 |
Gender inequalities in the treatment of osteoporosis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium, Dietary; Databases, Factual; Denosumab; Diphosphonates; Drug Utilization; Europe; Female; Finland; Healthcare Disparities; Humans; Hungary; Male; Middle Aged; Norway; Osteoporosis; Sex Factors; Socioeconomic Factors; Thiophenes; Vitamin D | 2015 |
Efficacy, effectiveness and side effects of medications used to prevent fractures.
Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid | 2015 |
Strontium still authorised despite an unfavourable opinion of the European Pharmacovigilance committee.
Topics: Advisory Committees; Bone Density Conservation Agents; Drug Approval; Europe; Evidence-Based Medicine; Humans; Osteoporosis; Patient Safety; Pharmacovigilance; Risk Assessment; Risk Factors; Thiophenes; Treatment Outcome | 2015 |
A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy.
Topics: Alendronate; Bone Density Conservation Agents; Case-Control Studies; Female; Humans; Italy; Middle Aged; Osteoporosis; Polymorphism, Single Nucleotide; Postmenopause; Receptors, Calcitriol; Thiophenes; Treatment Outcome | 2015 |
Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats.
Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Cell Line; Female; Glucocorticoids; Male; Mice; Mice, Inbred Strains; Osteoporosis; Rats; Rats, Wistar; Thiophenes; Up-Regulation | 2015 |
Strontium ranelate improves the interaction of osteoblastic cells with titanium substrates: Increase in cell proliferation, differentiation and matrix mineralization.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Calcification, Physiologic; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Male; Mice; Mice, Inbred BALB C; Osteoblasts; Osteogenesis; Osteoporosis; Thiophenes; Titanium | 2015 |
Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis.
Topics: Animals; Bone Density; Disease Models, Animal; Female; Femur; Lumbar Vertebrae; Osteoporosis; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Thiophenes; Vibration | 2017 |
Increased risk of strontium ranelate-related SJS/TEN is associated with HLA.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Asian People; Case-Control Studies; China; Female; Genetic Predisposition to Disease; HLA-A Antigens; HLA-B Antigens; Humans; Leukocytes, Mononuclear; Male; Osteoporosis; Retrospective Studies; Stevens-Johnson Syndrome; Thiophenes | 2016 |
Strontium ranelate increases osteoblast activity.
Topics: 3T3 Cells; Animals; Bone Resorption; Calcification, Physiologic; Cell Differentiation; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibronectins; Gene Expression Regulation, Developmental; Mice; Osteoblasts; Osteogenesis; Osteopontin; Osteoporosis; Thiophenes | 2016 |
Letter to the Editor: Strontium Ranelate in the Treatment of Osteoporosis: A Possible Mechanism.
Topics: Aged; Bone Density Conservation Agents; Bone Resorption; Female; Fractures, Bone; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes | 2016 |
The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Fracture Healing; Fractures, Bone; Osteoporosis; Osteotomy; Ovariectomy; Rats; Rats, Sprague-Dawley; Teriparatide; Thiophenes; Vibration | 2016 |
The incorporation of fluoride and strontium in hydroxyapatite affects the composition, structure, and mechanical properties of human cortical bone.
Topics: Adult; Aged; Bone and Bones; Durapatite; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Thiophenes | 2017 |
Effects of Strontium Ranelate on Spinal Interbody Fusion Surgery in an Osteoporotic Rat Model.
Topics: Animals; Biomechanical Phenomena; Bone Density; Calcium; Disease Models, Animal; Female; Osteoporosis; Peptide Fragments; Procollagen; Rats, Sprague-Dawley; Spinal Fusion; Strontium; Tartrate-Resistant Acid Phosphatase; Thiophenes; X-Ray Microtomography | 2017 |
Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment?
Topics: Back Pain; Bone Density; Bone Density Conservation Agents; Female; Femur; Humans; Lactation; Lumbar Vertebrae; Organometallic Compounds; Osteoporosis; Polycystic Ovary Syndrome; Postpartum Period; Pregnancy; Pregnancy Complications; Radiography; Severity of Illness Index; Thiophenes; Thoracic Vertebrae; Young Adult | 2009 |
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Bone Density Conservation Agents; Bone Remodeling; Compressive Strength; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Lumbar Vertebrae; Organometallic Compounds; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Strontium; Thiophenes; X-Ray Microtomography | 2009 |
Strontium ranelate-induced DRESS syndrome: first two case reports.
Topics: Aged; Anti-Inflammatory Agents; Bone Density Conservation Agents; Chemical and Drug Induced Liver Injury; Dexamethasone; Drug Eruptions; Eosinophilia; Fatal Outcome; Female; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2009 |
Effects of bone anabolic agents on bone ultrastructure.
Topics: Anabolic Agents; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Haplorhini; Humans; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Rats; Thiophenes | 2009 |
Synthesis, characterization of strontium-bile acid salts and their bioactivity vs. the anti-osteoporosis drug strontium ranelate.
Topics: Bile Acids and Salts; Cell Differentiation; Cells, Cultured; Humans; Organometallic Compounds; Osteoclasts; Osteoporosis; Strontium; Structure-Activity Relationship; Thiophenes | 2009 |
Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Female; Gene Expression Regulation; Humans; Mice; Models, Chemical; Osteoporosis; Ovariectomy; Promoter Regions, Genetic; Rats; Thiophenes | 2009 |
Could strontium ranelate have a synergistic role in the treatment of osteoporosis?
Topics: Animals; Bone Density Conservation Agents; Drug Synergism; Organometallic Compounds; Osteoporosis; Rats; Thiophenes | 2009 |
Re: "Effect of long-term treatment with strontium ranelate on bone strontium content" by Bärenholdt et al. (Bone, 2009).
Topics: Absorptiometry, Photon; Barium; Bone and Bones; Bone Density; Female; Humans; Models, Biological; Organometallic Compounds; Osteoporosis; Reproducibility of Results; Strontium; Thiophenes; Time Factors | 2009 |
Strontium ranelate: new perspectives for the management of osteoporosis.
Topics: Bone Density Conservation Agents; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2009 |
About the comparison of two anabolic agents, teriparatide and strontium ranelate, in treated osteoporotic women.
Topics: Anabolic Agents; Female; Humans; Organometallic Compounds; Osteoblasts; Osteoporosis; Teriparatide; Thiophenes | 2009 |
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Denmark; Diphosphonates; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Pulmonary Embolism; Raloxifene Hydrochloride; Thiophenes; Venous Thromboembolism | 2010 |
Strontium: confusion and hallucinations. Do not use strontium.
Topics: Bone Density Conservation Agents; Confusion; Europe; Hallucinations; Humans; Organometallic Compounds; Osteoporosis; Strontium; Thiophenes | 2009 |
Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Bone Screws; Coated Materials, Biocompatible; Combined Modality Therapy; Durapatite; Female; Materials Testing; Organometallic Compounds; Osseointegration; Osteoporosis; Ovariectomy; Prosthesis Implantation; Rats; Rats, Sprague-Dawley; Thiophenes; Titanium; X-Ray Microtomography | 2010 |
Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized
Topics: Anabolic Agents; Animals; Benzofurans; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Cell Line; Female; Lethal Dose 50; Male; Mice; Osteoporosis; Ovariectomy; Rats; Stereoisomerism; Structure-Activity Relationship; Thiophenes; Up-Regulation | 2010 |
Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
Topics: Animals; Bone Density Conservation Agents; Calcium; Cauda Equina; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fractures, Spontaneous; Lumbar Vertebrae; Mice; Mice, Transgenic; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Spinal Fractures; Stress, Mechanical; Strontium; Thiophenes; Tibia | 2011 |
[Preventive and therapeutic effect of strontium ranelate on osteoporosis in rats subjected to simulated weightlessness].
Topics: Animals; Male; Organometallic Compounds; Osteoporosis; Random Allocation; Rats; Rats, Sprague-Dawley; Thiophenes; Weightlessness Simulation | 2010 |
Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Male; Organometallic Compounds; Osteocalcin; Osteoporosis; Peptides; Teriparatide; Thiophenes | 2010 |
The mechanism of Cordyceps sinensis and strontium in prevention of osteoporosis in rats.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Collagen Type I; Cordyceps; Interferon-gamma; Isoenzymes; Organometallic Compounds; Osteoporosis; Rats; Strontium; Tartrate-Resistant Acid Phosphatase; Thiophenes | 2011 |
How to prevent glucocorticoid-induced osteoporosis.
Topics: Bone Density Conservation Agents; Etidronic Acid; Glucocorticoids; Humans; Organometallic Compounds; Osteoporosis; Risedronic Acid; Thiophenes | 2010 |
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Denmark; Diphosphonates; Female; Femoral Fractures; Hip Fractures; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Thiophenes | 2011 |
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
Topics: Aged; Aged, 80 and over; Australian Capital Territory; Bone Density Conservation Agents; Diphosphonates; Drug Prescriptions; Female; Hip Fractures; Humans; Incidence; Jaw Diseases; Male; Middle Aged; Organometallic Compounds; Osteonecrosis; Osteoporosis; Prevalence; Thiophenes | 2010 |
Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Etidronic Acid; Female; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Male; Medication Adherence; Middle Aged; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Registries; Retrospective Studies; Risedronic Acid; Sweden; Thiophenes | 2011 |
Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Humans; Middle Aged; Organometallic Compounds; Osteoporosis; Teriparatide; Thiophenes | 2011 |
Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
Topics: Administration, Oral; Aged; Alcoholism; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Case-Control Studies; Cohort Studies; Denmark; Diabetes Complications; Diphosphonates; Drug Therapy; Etidronic Acid; Female; Humans; Jaw Diseases; Male; Neoplasms; Organometallic Compounds; Osteitis; Osteomyelitis; Osteoporosis; Parathyroid Hormone; Periostitis; Radiotherapy; Raloxifene Hydrochloride; Risk Factors; Sjogren's Syndrome; Strontium; Thiophenes | 2012 |
Microarchitecture and nanomechanical properties of trabecular bone after strontium administration in osteoporotic goats.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Calcium; Disease Models, Animal; Drug Therapy, Combination; Female; Goats; Humans; Lumbar Vertebrae; Organometallic Compounds; Osteoporosis; Ovariectomy; Random Allocation; Strontium; Thiophenes; Treatment Outcome; X-Ray Microtomography | 2012 |
Uses and misuses of statistics: the case of strontium ranelate and the number needed to treat.
Topics: Bone Density Conservation Agents; Drug Industry; Fractures, Bone; Humans; Numbers Needed To Treat; Organometallic Compounds; Osteoporosis; Randomized Controlled Trials as Topic; Thiophenes | 2011 |
Effects of strontium ranelate on osseointegration of titanium implant in osteoporotic rats.
Topics: Acid Phosphatase; Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Coated Materials, Biocompatible; Female; Femur; Isoenzymes; Microscopy, Electron, Scanning; Organometallic Compounds; Osseointegration; Osteocalcin; Osteoporosis; Ovariectomy; Prosthesis Implantation; Rats; Rats, Sprague-Dawley; Tartrate-Resistant Acid Phosphatase; Thiophenes; Titanium; X-Ray Microtomography | 2012 |
Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis.
Topics: Animals; Biomechanical Phenomena; Biomedical Engineering; Bone Density; Bone Density Conservation Agents; Botulinum Toxins; Disease Models, Animal; Elastic Modulus; Female; Organometallic Compounds; Osteoporosis; Paralysis; Rats; Rats, Sprague-Dawley; Thiophenes; X-Ray Microtomography | 2012 |
Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Cardiovascular Diseases; Consensus; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Neoplasms; Organometallic Compounds; Osteoporosis; Selective Estrogen Receptor Modulators; Stroke; Thiophenes; Vitamin D | 2012 |
Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.
Topics: Bone Density Conservation Agents; Cohort Studies; Diphosphonates; Humans; Medication Adherence; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Retrospective Studies; Thiophenes; Vitamin D | 2012 |
Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons.
Topics: Adult; Age Factors; Aged; Algorithms; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Etidronic Acid; Female; Fractures, Bone; Hip Fractures; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Risedronic Acid; Spinal Fractures; Thiophenes | 2012 |
Strontium ranelate--a promising therapeutic principle in osteoporosis.
Topics: Bone Density Conservation Agents; Female; Humans; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Radiography; Thiophenes | 2012 |
Strontium ranelate treatment improves oxidative damage in osteoporotic rat model.
Topics: Administration, Oral; Animals; Antioxidants; Bone Density Conservation Agents; Catalase; Disease Models, Animal; Drug Administration Schedule; Female; Glutathione Peroxidase; Humans; Kidney; Lipid Peroxidation; Liver; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiophenes | 2012 |
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis.
Topics: 17-Hydroxysteroid Dehydrogenases; Amides; Animals; Bone Density Conservation Agents; Callithrix; Catalytic Domain; Cell Line, Tumor; Cell-Free System; Enzyme Assays; Estradiol Dehydrogenases; HEK293 Cells; Humans; Mice; Microsomes; Models, Molecular; Osteoporosis; Rats; Structure-Activity Relationship; Thiophenes | 2013 |
[Osteoporosis in the man: broad indication for strontium ranelate].
Topics: Aged; Bone Density; Bone Density Conservation Agents; Evidence-Based Medicine; Guideline Adherence; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Thiophenes | 2012 |
Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.
Topics: Aged; Belgium; Bone Density; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Costs; Female; Femur Neck; Health Care Costs; Humans; Incidence; Lumbar Vertebrae; Male; Models, Econometric; Osteoporosis; Osteoporotic Fractures; Quality-Adjusted Life Years; Thiophenes | 2013 |
Treatment of osteoporosis and hip fractures in a Spanish health area.
Topics: Bone Density Conservation Agents; Diphosphonates; Hip Fractures; Humans; Longitudinal Studies; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Retrospective Studies; Spain; Thiophenes | 2013 |
S 12911-2 inhibits osteoclastic bone resorption in vitro.
Topics: Animals; Animals, Newborn; Bone Resorption; Cell Culture Techniques; Cells, Cultured; Mice; Mice, Inbred Strains; Organ Culture Techniques; Organometallic Compounds; Osteoclasts; Osteogenesis; Osteoporosis; Thiophenes | 2003 |
Strontium strengthens some bones.
Topics: Bone Density; Female; Humans; Organometallic Compounds; Osteoporosis; Spinal Fractures; Thiophenes | 2004 |
Bone anabolic agents: the unanswered queries.
Topics: Alendronate; Anabolic Agents; Animals; Bone Resorption; Clinical Trials as Topic; Female; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes | 2004 |
Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Diseases; Bone Resorption; Calcium; Densitometry; Dose-Response Relationship, Drug; Female; Insulin-Like Growth Factor I; Male; Organometallic Compounds; Osteoporosis; Radioimmunoassay; Rats; Rats, Inbred F344; Strontium; Thiophenes; Tibia | 2004 |
On some osteoporosis analyses.
Topics: Analysis of Variance; Bone Density; Calcium; Complement System Proteins; Estradiol; Female; Femur Neck; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2005 |
Strontium ranelate for the treatment of osteoporosis.
Topics: Bone Density; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2005 |
Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
Topics: Animals; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Dose-Response Relationship, Drug; Female; Haplorhini; Ions; Macaca fascicularis; Male; Microradiography; Organometallic Compounds; Osteogenesis; Osteoporosis; Strontium; Thiophenes; Time Factors; X-Ray Diffraction; X-Rays | 2005 |
Long-term effect of strontium ranelate treatment on BMD.
Topics: Algorithms; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Fractures, Bone; Humans; Macaca fascicularis; Organometallic Compounds; Osteoporosis; Strontium; Thiophenes | 2005 |
Fighting osteoporosis on two fronts.
Topics: Bone Density; Bone Density Conservation Agents; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis; Thiophenes | 2006 |
Preclinical assessment of gastrooesophageal tolerance of the new antiosteoporotic drug strontium ranelate: an endoscopic study in monkeys.
Topics: Administration, Oral; Animals; Biopsy; Drug Evaluation, Preclinical; Duodenum; Endoscopy, Gastrointestinal; Esophagoscopy; Esophagus; Macaca fascicularis; Models, Animal; Organometallic Compounds; Osteoporosis; Stomach; Strontium; Thiophenes; Time Factors | 2006 |
Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment.
Topics: Bone Density; Female; Femur Neck; Follow-Up Studies; Hip; Humans; Models, Theoretical; Organometallic Compounds; Osteoporosis; Postmenopause; Spine; Thiophenes; Time Factors; Tomography, X-Ray Computed; Withholding Treatment | 2006 |
[DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?].
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Spontaneous; Humans; Ibandronic Acid; Male; Middle Aged; Minimally Invasive Surgical Procedures; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Peptide Fragments; Recombinant Proteins; Spinal Fractures; Teriparatide; Thiophenes | 2006 |
[Osteoporosis priority: Reduce the number of fractures].
Topics: Absorptiometry, Photon; Age Factors; Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fractures, Bone; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Spinal Fractures; Teriparatide; Thiophenes; Time Factors | 2006 |
Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis.
Topics: Aged; Bleeding Time; Female; Hemostatics; Humans; Organometallic Compounds; Osteoporosis; Prospective Studies; Thiophenes; Time Factors | 2007 |
An analysis of which anti-osteoporosis therapeutic regimen would improve compliance in a population of elderly adults.
Topics: Aged; Cohort Studies; Diphosphonates; Drug Administration Schedule; Fasting; Female; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Patient Compliance; Patient Satisfaction; Posture; Raloxifene Hydrochloride; Registries; Single-Blind Method; Surveys and Questionnaires; Teriparatide; Thiophenes; Twins | 2007 |
Osteopontin deficiency enhances anabolic action of EP4 agonist at a sub-optimal dose in bone.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Biomarkers; Cells, Cultured; Collagen Type I; Drug Administration Schedule; Female; Femur; Gene Expression; Injections, Subcutaneous; Mice; Mice, Knockout; Osteoclasts; Osteogenesis; Osteopontin; Osteoporosis; Ovariectomy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sp7 Transcription Factor; Sulfhydryl Compounds; Thiophenes; Tomography, X-Ray Computed; Transcription Factors | 2007 |
[The necessity of cost-effectiveness analysis in osteoporosis].
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Decision Making; Diphosphonates; Female; Fractures, Bone; Health Care Costs; Hip Fractures; Hormone Replacement Therapy; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Quality of Life; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D | 2007 |
By the way, doctor. What can you tell me about the mineral strontium, which is advertised for treating osteoporosis?
Topics: Bone Density; Bone Density Conservation Agents; Female; Humans; Organometallic Compounds; Osteoporosis; Strontium; Thiophenes | 2007 |
[Advances in the field of osteoporosis].
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Glucocorticoids; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Teriparatide; Thiophenes; Zoledronic Acid | 2007 |
[Therapeutics issues in osteoporosis].
Topics: Aged; Bone Remodeling; Bone Resorption; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Spontaneous; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes | 2007 |
Studies on osteoporosis IV. Effect of benzo[b]thiophene-2- and dibenzothiophene-4-carboxylic acid on heparin accelerated osteoporosis.
Topics: Animals; Female; Heparin; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Osteoporosis; Thiophenes | 1980 |
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone Density; Bone Development; Bone Resorption; Calcium; Estradiol; Estrogens; Female; Magnesium; Organometallic Compounds; Osteocalcin; Osteoporosis; Ovariectomy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Thiophenes; Tibia; Uncoupling Agents | 1993 |
S 12911.
Topics: Animals; Bone Resorption; Drugs, Investigational; Female; Humans; Organometallic Compounds; Osteoporosis; Rats; Thiophenes; Uncoupling Agents | 1999 |
p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas.
Topics: Arthritis; Enzyme Inhibitors; Furans; Humans; Inhibitory Concentration 50; Interleukin-6; Mitogen-Activated Protein Kinases; Molecular Structure; Osteoporosis; p38 Mitogen-Activated Protein Kinases; Pyrroles; Thiophenes; Tumor Cells, Cultured; Urea | 2001 |
alpha(v)beta(3) Antagonists based on a central thiophene scaffold.
Topics: Animals; Binding Sites; Carbamates; Cell Adhesion; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Guanidine; Osteoporosis; Parathyroidectomy; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Receptors, Vitronectin; Sensitivity and Specificity; Sulfonamides; Thiophenes; Thyroidectomy | 2001 |